Tag: Pharmaceutical mergers and acquisitions

Aspen exits Asia-Pacific business in $1.6 billion deal

Aspen Pharmacare exits Asia-Pacific in $1.6 billion deal, refocusing on core growth markets and reducing debt for stronger returns.

Feyisayo Ajayi Feyisayo Ajayi